Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Terminated 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 20Thoracic 12Genitourinary 12Breast 10Tumor-Agnostic 7Lymphoid 7Other hematologic neoplasm 4Gynecologic 4Dermatologic 4CNS 4Other 2Myeloid 2Classical hematology 2Sarcoma 1Plasma cell 1Head & Neck 1

Conditions

Wilms Tumor 1Venous Thromboembolism 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Hepatic Veno-Occlusive Disease 1

Interventions

Cyclophosphamide 94fludarabine phosphate 87Busulfan 64Cyclosporine 57Epoetin Alfa 55Peripheral Blood Stem Cell Transplantation 54Mycophenolic Acid 54Whole-Body Irradiation 53fludarabine 45Antilymphocyte Serum 43Filgrastim 41Cytarabine 41Melphalan 40Tacrolimus 39Darbepoetin alfa 39Methotrexate 34Radiotherapy 33Cord Blood Stem Cell Transplantation 28Granulocyte Colony-Stimulating Factor 23apixaban 22Methylprednisolone 22Rivaroxaban 21Etoposide 21Thiotepa 17Dalteparin 17eltrombopag 16ferric carboxymaltose 14epoetin beta 14Daunorubicin 14Azacitidine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hematologic Tests × Classical hematology × Clear all
NCT04168788 2019-11-19

MVO

University Hospital, Angers

Phase NA Unknown
150 enrolled
Classical hematologyGenitourinaryLymphoidOther hematologic neoplasm

Hepatic Veno-Occlusive Disease, Wilms Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01608919 2015-08-10

Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection

University of Colorado, Denver

Phase NA Terminated
4 enrolled
Classical hematology

Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡